Literature DB >> 23727164

Kidney failure: aims for the next 10 years and barriers to success.

Giuseppe Remuzzi1, Ariela Benigni, Fredric O Finkelstein, Jean-Pierre Grunfeld, Dominique Joly, Ivor Katz, Zhi-Hong Liu, Toshio Miyata, Norberto Perico, Bernardo Rodriguez-Iturbe, Luca Antiga, Franz Schaefer, Arrigo Schieppati, Robert W Schrier, Marcello Tonelli.   

Abstract

Although in some parts of the world acute and chronic kidney diseases are preventable or treatable disorders, in many other regions these diseases are left without any care. The nephrology community needs to commit itself to reduction of this divide between high-income and low-income regions. Moreover, new and exciting developments in fields such as pharmacology, genetic, or bioengineering, can give a boost, in the next decade, to a new era of diagnosis and treatment of kidney diseases, which should be made available to more patients.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23727164     DOI: 10.1016/S0140-6736(13)60438-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

Review 1.  Kidney care in Haiti--the role of partnerships.

Authors:  Brian D Remillard; Jean H Buteau; Philip Cléophat
Journal:  Nat Rev Nephrol       Date:  2014-12-16       Impact factor: 28.314

2.  The risk of chronic kidney disease and mortality are increased after community-acquired acute kidney injury.

Authors:  Karina Soto; Pedro Campos; Iola Pinto; Bruno Rodrigues; Francisca Frade; Ana Luísa Papoila; Prasad Devarajan
Journal:  Kidney Int       Date:  2016-09-19       Impact factor: 10.612

3.  An RNA interference screen identifies new avenues for nephroprotection.

Authors:  E R Zynda; B Schott; M Babagana; S Gruener; E Wernher; G D Nguyen; M Ebeling; E S Kandel
Journal:  Cell Death Differ       Date:  2015-11-13       Impact factor: 15.828

Review 4.  Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices.

Authors:  Bruce M Robinson; Tadao Akizawa; Kitty J Jager; Peter G Kerr; Rajiv Saran; Ronald L Pisoni
Journal:  Lancet       Date:  2016-05-22       Impact factor: 79.321

5.  Chronic kidney disease in low- and middle-income countries.

Authors:  John W Stanifer; Anthony Muiru; Tazeen H Jafar; Uptal D Patel
Journal:  Nephrol Dial Transplant       Date:  2016-02-04       Impact factor: 5.992

6.  FGF/FGFR2 Protects against Tubular Cell Death and Acute Kidney Injury Involving Erk1/2 Signaling Activation.

Authors:  Zhuo Xu; Xingwen Zhu; Mingjie Wang; Yibing Lu; Chunsun Dai
Journal:  Kidney Dis (Basel)       Date:  2020-02-07

7.  Effect of information and telephone-guided access to community support for people with chronic kidney disease: randomised controlled trial.

Authors:  Tom Blakeman; Christian Blickem; Anne Kennedy; David Reeves; Peter Bower; Hannah Gaffney; Caroline Gardner; Victoria Lee; Praksha Jariwala; Shoba Dawson; Rahena Mossabir; Helen Brooks; Gerry Richardson; Eldon Spackman; Ivaylo Vassilev; Carolyn Chew-Graham; Anne Rogers
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

8.  Partial least squares based gene expression analysis in renal failure.

Authors:  Shuang Ding; Yinhai Xu; Tingting Hao; Ping Ma
Journal:  Diagn Pathol       Date:  2014-07-05       Impact factor: 2.644

9.  Translational nephrology: what translational research is and a bird's-eye view on translational research in nephrology.

Authors:  Alberto Ortiz
Journal:  Clin Kidney J       Date:  2015-01-28

10.  Non-Medical Risk Factors as Avoidable Determinants of Excess Mortality in Children with Chronic Kidney Disease. A Prospective Cohort Study in Nicaragua, a Model Low Income Country.

Authors:  Giovanni Montini; Alberto Edefonti; Yajaira Silva Galán; Mabel Sandoval Díaz; Marta Medina Manzanarez; Giuseppina Marra; Fabio Robusto; Gianni Tognoni; Fabio Sereni
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.